Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
Guardado en:
Autores principales: | Hiroshi Mukae, Noriho Sakamoto, Naoki Hosogaya, Kazuko Yamamoto, Haruo Yoshida, Kazuhiro Yatera, Koichi Izumikawa, Katsunori Yanagihara |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f80414f91374a768e8951cffc55ca4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship.
por: Norihito Kaku, et al.
Publicado: (2021) -
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Piotr Rzymski, et al.
Publicado: (2021) -
COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis
por: Clio Bilotta, et al.
Publicado: (2021) -
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
por: Marios Spanakis, et al.
Publicado: (2021) -
Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria
por: Oluseyi Ademola Adejumo, et al.
Publicado: (2021)